Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for Cancer Pain
NCT00676936Phase 3Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Apr 2008
- Primary completion
- Feb 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone in cancer pain, sponsored by Norwegian University of Science and Technology. Started Apr 2008; status: completed.
02
Drugs
methylprednisolone
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00676936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00676936.